Mentioned in ?
References in periodicals archive ?
(NYSE: PFE) has received US Food and Drug Administration approval for Retacrit (epoetin alfa-epbx), a biosimilar to Epogen and Procrit (epoetin alfa), the company said.
Pfizer announced the United States Food and Drug Administration approved RETACRIT, a biosimilar to Epogen and Procrit, for all indications of the reference product.
Food and Drug Administration as the first "biosimilar" to the anemia drugs Epogen and Procrit.
Among the drug class segments, erythropoietin stimulating agents, such as NeoRecormon, Procrit, and Arsanep, are expected to account for the largest share of the global cancer supportive care products market, followed by granulocyte colony-stimulating factors and others.
She also received Procrit for anemia and her hypertension and diabetes mellitus type II were controlled with Lasix, Lisinopril, Hydrochlorothiazide, and Metformin.
My brands include Band-Aid, Listerine, Tylenol, Splenda, Motrin, Visine, Stayfree, K-Y, Rogaine, Procrit and Remicade.
Together, they control a significant portion of the AIDS drug market with drugs that include Prezista, Intelence, Endurant and Procrit.
Darbepoetin alfa, marketed as Arandesp, and epoetin alfa, marketed as Epogen o and Procrit, are the ESAs approved in the United States; they are administered as often as one to three times per week.
The Food and Drug Administration released Friday reducing the dosage for anemia drugs Procrit, Epogen and Aranesp for patients with chronic kidney disease due to increased risks of stroke, blood clots and death.
The three antianemia drugs on the market (Procrit, Aranesp and Epogen) had combined sales of $6.3 billion last year.